These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 28139360)

  • 1. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.
    Alderman T; Addington J; Bearden C; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2015 Dec; 9(6):467-75. PubMed ID: 24576057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of clinical high-risk states for psychosis beyond conversion.
    Michel C; Ruhrmann S; Schimmelmann BG; Klosterkötter J; Schultze-Lutter F
    Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):39-48. PubMed ID: 28054132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
    Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affect recognition in people at clinical high risk of psychosis.
    Addington J; Piskulic D; Perkins D; Woods SW; Liu L; Penn DL
    Schizophr Res; 2012 Sep; 140(1-3):87-92. PubMed ID: 22763425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive validity of conversion from the clinical high risk syndrome to frank psychosis.
    Yoviene Sykes LA; Ferrara M; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Mathalon DH; Seidman LJ; Tsuang MT; Walker EF; McGlashan TH; Woodberry KA; Powers AR; Ponce AN; Cahill JD; Pollard JM; Srihari VH; Woods SW
    Schizophr Res; 2020 Feb; 216():184-191. PubMed ID: 31864837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting psychosis in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Kalska H; Mustonen U; Laajasalo T; Moilanen K; Huttunen M; Cannon TD; Suvisaari J; Therman S
    Schizophr Res; 2014 Sep; 158(1-3):1-6. PubMed ID: 25015028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.
    Lee TY; Shin YS; Shin NY; Kim SN; Jang JH; Kang DH; Kwon JS
    Schizophr Res; 2014 Mar; 153(1-3):48-53. PubMed ID: 24529365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study.
    Zhang T; Li H; Woodberry KA; Seidman LJ; Zheng L; Li H; Zhao S; Tang Y; Guo Q; Lu X; Zhuo K; Qian Z; Chow A; Li C; Jiang K; Xiao Z; Wang J
    Schizophr Res; 2014 Feb; 152(2-3):391-9. PubMed ID: 24387999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Various neurocognitive deficits and conversion risk in individuals at clinical high risk for psychosis.
    Mourik K; Decrescenzo P; Brucato G; Gill KE; Arndt L; Kimhy D; Keilp JG; Girgis RR
    Early Interv Psychiatry; 2017 Jun; 11(3):250-254. PubMed ID: 26663764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory P300 as a predictor of short-term prognosis in subjects at clinical high risk for psychosis.
    Kim M; Lee TY; Lee S; Kim SN; Kwon JS
    Schizophr Res; 2015 Jul; 165(2-3):138-44. PubMed ID: 25956629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.
    Addington J; Shah H; Liu L; Addington D
    Schizophr Res; 2014 Mar; 153(1-3):64-7. PubMed ID: 24439270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of premorbid functioning in individuals at clinical high risk of psychosis.
    Lyngberg K; Buchy L; Liu L; Perkins D; Woods S; Addington J
    Schizophr Res; 2015 Dec; 169(1-3):209-213. PubMed ID: 26589390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.
    Rosengard RJ; Malla A; Mustafa S; Iyer SN; Joober R; Bodnar M; Lepage M; Shah JL
    JAMA Psychiatry; 2019 Jan; 76(1):61-70. PubMed ID: 30304442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomalous self-experiences are strongly associated with negative symptoms in a clinical high-risk for psychosis sample.
    Værnes TG; Røssberg JI; Møller P
    Compr Psychiatry; 2019 Aug; 93():65-72. PubMed ID: 31351243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and prediction of clinical high risk of psychosis in Chinese outpatients using two-stage screening.
    Xu L; Wang Y; Cui H; Tang Y; Wang J; Tang X; Zhang B; Wei Y; Zhu Y; Jiang L; Qian Z; Li H; Zhang T; Wang J
    Schizophr Res; 2018 Dec; 202():284-290. PubMed ID: 29929774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.
    Brodey BB; Girgis RR; Favorov OV; Addington J; Perkins DO; Bearden CE; Woods SW; Walker EF; Cornblatt BA; Brucato G; Walsh B; Elkin KA; Brodey IS
    Schizophr Res; 2018 Jul; 197():516-521. PubMed ID: 29358019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recency and intensification of positive symptoms enhance prediction of conversion to syndromal psychosis in clinical high-risk patients.
    Brucato G; First MB; Dishy GA; Samuel SS; Xu Q; Wall MM; Small SA; Masucci MD; Lieberman JA; Girgis RR
    Psychol Med; 2021 Jan; 51(1):112-120. PubMed ID: 31658912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.